Back to Top

tarloxotinib

ESMO 2020 Preview, part 1: Further slicing and dicing of the EGFR mutation pie

Next generation TKIs are developed to target a broader spectrum of EGFR mutations. But can they overcome the challenges presented by exon 20 insertion mutations?

Subscribe to RSS - tarloxotinib